All Stories

  1. Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
  2. Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients
  3. Perturbation of Copper Homeostasis Sensitizes Cancer Cells to Elevated Temperature
  4. Radiosensitization by hyperthermia critically depends on the time interval
  5. Quantification of tissue property and perfusion uncertainties in hyperthermia treatment planning: Multianalysis using polynomial chaos expansion
  6. Delivering Energy using Localized Hyperthermia Systems
  7. Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
  8. Application of HIPEC simulations for optimizing treatment delivery strategies
  9. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells
  10. OC-0100 Short course radiation improves pain from pancreatic cancer: A prospective phase II study (NTR5143)
  11. Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
  12. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose
  13. Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
  14. Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer
  15. Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells
  16. Comparison of the clinical performance of a hybrid Alba 4D and the AMC-4 locoregional hyperthermia systems
  17. A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers
  18. Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use
  19. Deep learning DCE-MRI parameter estimation: Application in pancreatic cancer
  20. Validation and practical use of Plan2Heat hyperthermia treatment planning for capacitive heating
  21. Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
  22. A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
  23. A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area
  24. Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial
  25. Adapt2Heat: treatment planning-assisted locoregional hyperthermia by on-line visualization, optimization and re-optimization of SAR and temperature distributions
  26. Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters
  27. A scalable setup for hyperthermic intravesical chemotherapy in rodents
  28. Improving Prediction of the Potential Distribution Induced by Cylindrical Electrodes within a Homogeneous Rectangular Grid during Irreversible Electroporation
  29. Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment
  30. The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review
  31. Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia
  32. Fast Adaptive Temperature-Based Re-Optimization Strategies for On-Line Hot Spot Suppression during Locoregional Hyperthermia
  33. SP-0340 Biological rationale for combining heat and radiation
  34. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
  35. Improved unsupervised physics‐informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients
  36. Creating a cumulative equivalent thermal isoeffect dosimetry model in several ex vivo tissue models mimicking focal laser ablation treatment of the prostate
  37. PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation
  38. Hyperthermia-Based Anti-Cancer Treatments
  39. Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments
  40. Simulation of clinical focal laser ablation treatments to create a dosimetry model of the ablation zone using critical CEM43 values
  41. Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model
  42. Effect of gastrointestinal gas on the temperature distribution in pancreatic cancer hyperthermia treatment planning
  43. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
  44. Treatment planning facilitates clinical decision making for hyperthermia treatments
  45. Clinical Feasibility of a High-Resolution Thermal Monitoring Sheet for Superficial Hyperthermia in Breast Cancer Patients
  46. A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
  47. HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings
  48. Two high-resolution thermal monitoring sheets for clinical superficial hyperthermia
  49. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
  50. Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
  51. Experimental validation of a thermophysical fluid model for use in a hyperthermia treatment planning system
  52. Deep learning‐based reconstruction of in vivo pelvis conductivity with a 3D patch‐based convolutional neural network trained on simulated MR data
  53. Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
  54. Dedicated 70 MHz RF systems for hyperthermia of challenging tumor locations
  55. Modelling Curved Contact Flexible Microstrip Applicators for Patient-Specific Superficial Hyperthermia Treatment Planning
  56. Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines
  57. Hyperthermia treatment planning: clinical application and ongoing research
  58. Loco-regional Hyperthermia Delivery: Patient-specific set-up Procedures for Treatment Optimisation
  59. Heating technology for malignant tumors: a review
  60. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer
  61. Advanced patient-specific hyperthermia treatment planning
  62. Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems
  63. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review
  64. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series
  65. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer
  66. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
  67. Combining 70MHz and 434MHz or wIRA Hyperthermia Applicators for Optimal Coverage of Semi-Deep Tumour Sites
  68. Transceive phase mapping using the PLANET method and its application for conductivity mapping in the brain
  69. Hyperthermia Treatment Planning Including Convective Flow in Cerebrospinal Fluid for Brain Tumour Hyperthermia Treatment Using a Novel Dedicated Paediatric Brain Applicator
  70. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies
  71. The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
  72. Accuracy and precision of electrical permittivity mapping at 3T: the impact of three mapping techniques
  73. Quality assurance guidelines for interstitial hyperthermia
  74. Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
  75. Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
  76. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review
  77. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies.
  78. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies
  79. Re‑irradiation plus hyperthermia for recurrent pediatric sarcoma; a simulation study to investigate feasibility
  80. Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region
  81. The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients
  82. Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments
  83. Technical and Clinical Evaluation of the ALBA-4D 70MHz Loco-Regional Hyperthermia System
  84. Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
  85. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
  86. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose
  87. Analysis of clinical data to determine the minimum number of sensors required for adequate skin temperature monitoring of superficial hyperthermia treatments
  88. Locoregional hyperthermia of deep-seated tumors applied with capacitive and radiative systems: a simulation study
  89. Reirradiation + hyperthermia for recurrent breast cancer en cuirasse
  90. The clinical benefit of hyperthermia in pancreatic cancer: a systematic review
  91. Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia
  92. Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots
  93. Thermal Skin Damage During Reirradiation and Hyperthermia Is Time-Temperature Dependent
  94. Development of a 70 MHz unit for hyperthermia treatment of deep-seated breast tumors
  95. Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i
  96. Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation
  97. Progress and future directions in hyperthermia treatment planning
  98. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
  99. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
  100. A flexible 70 MHz phase-controlled double waveguide system for hyperthermia treatment of superficial tumours with deep infiltration
  101. Colorectal cancer at high risk of peritoneal metastases; long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives
  102. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies
  103. Correction: Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies
  104. Planning, optimisation and evaluation of hyperthermia treatments
  105. Sensitizing thermochemotherapy with a PARP1-inhibitor
  106. Quality assurance guidelines for superficial hyperthermia clinical trials
  107. Targeting therapy-resistant cancer stem cells by hyperthermia
  108. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  109. A comparison of the heating characteristics of capacitive and radiative superficial hyperthermia
  110. Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies
  111. 3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments
  112. A 70 MHz double waveguide set-up for hyperthermia of deep superficial tumors
  113. Development of a 70 MHz unit for hyperthermia treatment of deep seated breast tumors
  114. Analysis of enhancement at small and large radiation doses for effectiveness of inactivation in cultured cells by combining two agents with radiation
  115. SU-F-J-05: The Effect of Air Pockets in the Urinary Bladder During Bladder Hyperthermia Treatment
  116. The use of hyperthermia in the treatment of bladder cancer
  117. Thermal dosimetry for bladder hyperthermia treatment. An overview
  118. B1-based SAR reconstruction using contrast source inversion–electric properties tomography (CSI-EPT)
  119. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations
  120. OC-0054: Reirradiation+hyperthermia for recurrent breast canceren-cuirasse in previously irradiated area
  121. PO-0723: Short time interval between radiation and hyperthermia improves treatment outcome in cervical cancer
  122. EP-2024: Optimising hyperthermia induced radiosensitisaion for treating HPV+ cervical tumours
  123. OC-0548: Hyperthermia treatment planning in the pelvis using thermophysical fluid modelling of the bladder
  124. Hyperthermia treatment planning for cervical cancer patients based on electrical conductivity tissue properties acquiredin vivowith EPT at 3 T MRI
  125. Rib fractures after reirradiation plus hyperthermia for recurrent breast cancer
  126. Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
  127. In vivoelectric conductivity of cervical cancer patients based on $B_{1}^{+}$ maps at 3T MRI
  128. Thermoradiotherapy planning: Integration in routine clinical practice
  129. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis
  130. Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study
  131. Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future
  132. Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
  133. Current state of the art of regional hyperthermia treatment planning: a review
  134. A mixed frequency approach to optimize locoregional RF hyperthermia
  135. Development of a 27.12 MHz CC-LCF intraluminal applicator for hyperthermia of the esophagus
  136. CSI-EPT: A Contrast Source Inversion Approach for Improved MRI-Based Electric Properties Tomography
  137. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
  138. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
  139. Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating
  140. SP-0299: Technical aspects of hyperthermia: present and future
  141. EP-1271: Development of focused microwave hyperthermia of pediatric brain cance
  142. EP-1467: Meta-analysis of radiosensitivity and fractionation sensitivity of human tumours
  143. PO-0727: Thermophysical fluid modelling for loco-regional hyperthermia treatment of Non-Muscle Invasive Bladder Cancer
  144. OC-0065: Electrical tissue property imaging in patients using MRI to improve hyperthermia treatment planning
  145. OC-0334: Reirradiation plus hyperthermia for irresectable recurrent breast cancer; size matters
  146. Improved temperature monitoring and treatment planning for loco-regional hyperthermia treatments of Non-Muscle Invasive Bladder Cancer (NMIBC)
  147. P096 Optimization of bladder hyperthermia treatment for non-muscle invasive bladder cancer using loco-regional heating, 3D thermometry and hyperthermia treatment planning
  148. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis
  149. Toward Online Adaptive Hyperthermia Treatment Planning: Correlation Between Measured and Simulated Specific Absorption Rate Changes Caused by Phase Steering in Patients
  150. Meta-Analysis of Tumor Fractionation Sensitivities Based on Clinical Data
  151. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: A systematic review
  152. Feasibility of Electric Property Tomography of pelvic tumors at 3T
  153. Quantifying the Combined Effect of Radiation Therapy and Hyperthermia in Terms of Equivalent Dose Distributions
  154. EP-1762: Optimization of bladder hyperthermia treatment
  155. Novel Multisensor Probe for Monitoring Bladder Temperature During Locoregional Chemohyperthermia for Nonmuscle-Invasive Bladder Cancer: Technical Feasibility Study
  156. Fast thermal simulations and temperature optimization for hyperthermia treatment planning, including realistic 3D vessel networks
  157. Novel multi-sensor probe for monitoring bladder temperature during loco-regional chemo-hyperthermia for non-muscle invasive bladder cancer: technical feasibility study
  158. CSI-EPT: A novel contrast source approach to MRI based electric properties tomography and patient-specific SAR
  159. Thermal modelling using discrete vasculature for thermal therapy: A review
  160. PD-0585: Dose escalation by adding hyperthermia: a modelling study
  161. EMF methods for hyperthermia
  162. Specific absorption rate intersubject variability in 7T parallel transmit MRI of the head
  163. Dose-Guided Radiotherapy: Potential Benefit of Online Dose Recalculation for Stereotactic Lung Irradiation in Patients With Non-Small-Cell Lung Cancer
  164. Automatic delineation of body contours on cone-beam CT images using a delineation booster
  165. Radiosensitization with Hyperthermia and Chemotherapeutic Agents: Effects on Linear-Quadratic Parameters of Radiation Cell Survival Curves
  166. Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010
  167. Quality assurance for clinical studies in regional deep hyperthermia
  168. 5033 POSTER Re-irradiation Plus Hyperthermia for 415 Patients With Recurrent Breast Cancer in Previously Irradiated Area – the Amsterdam + Tilburg Experience
  169. Uncertainty in hyperthermia treatment planning: the need for robust system design
  170. Improved power steering with double and triple ring waveguide systems: The impact of the operating frequency
  171. 3D versus 2D steering in patient anatomies: A comparison using hyperthermia treatment planning
  172. Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus
  173. Optimization in hyperthermia treatment planning: The impact of tissue perfusion uncertainty
  174. The impact of the waveguide aperture size of the 3D 70 MHz AMC-8 locoregional hyperthermia system on tumour coverage
  175. Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model
  176. 452 Re-irradiation plus hyperthermia for recurrent breast cancer gives high local response and locoregional control
  177. SAR deposition by curved CFMA-434 applicators for superficial hyperthermia: Measurements and simulations
  178. Comparison of two different 70 MHz applicators for large extremity lesions: Simulation and application
  179. Elective re-irradiation and hyperthermia following resection of persistent locoregional recurrent breast cancer: A retrospective study
  180. Body Conformal Antennas for Superficial Hyperthermia: The Impact of Bending Contact Flexible Microstrip Applicators on Their Electromagnetic Behavior
  181. Quantification of the Contribution of Hyperthermia to Results of Cervical Cancer Trials: In Regard to Plataniotis and Dale (Int J Radiat Oncol Biol Phys 2009;73:1538–1544)
  182. Characteristics and performance evaluation of the capacitive Contact Flexible Microstrip Applicator operating at 70 MHz for external hyperthermia
  183. Accelerated ray tracing for radiotherapy dose calculations on a GPU
  184. PELVIC MALIGNANCIES TREATED WITH THE NEW 3D LOCOREGIONAL HYPERTHERMIA SYSTEM (AMC-8)
  185. Acceleration of high resolution temperature based optimization for hyperthermia treatment planning using element grouping
  186. Characteristics and performance evaluation of the capacitive Contact Flexible Microstrip Applicator operating at 70 MHz for external hyperthermia
  187. FDTD simulations to assess the performance of CFMA-434 applicators for superficial hyperthermia
  188. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer
  189. Chest wall radiation associated sarcomas are sensitive to reirradiation and hyperthermia
  190. Relation between body size and temperatures during locoregional hyperthermia of oesophageal cancer patients
  191. Artefacts in intracavitary temperature measurements during regional hyperthermia
  192. Theoretical comparison of intraluminal heating techniques
  193. Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application
  194. Delineation of potential hot spots for hyperthermia treatment planning optimisation
  195. On verification of hyperthermia treatment planning for cervical carcinoma patients
  196. Monitoring of response to preoperative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
  197. Reliability of temperature and SAR measurements at oesophageal tumour locations
  198. Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer
  199. 523 Improvement of locoregional hyperthermia treatments of oesophageal cancer using treatment planning
  200. High-resolution temperature-based optimization for hyperthermia treatment planning
  201. On estimation of the temperature maximum in intraluminal or intracavitary hyperthermia
  202. A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
  203. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the multi electrode current source (MECS) system
  204. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma—a feasibility study
  205. Clinical thermometry, using the 27 MHz multi-electrode current-source interstitial hyperthermia system in brain tumours
  206. Evaluation of the Treatment Planning of Interstitial Hyperthermia of Glioblastomas
  207. Spatial steering with quadruple electrodes in 27MHz capacitively coupled interstitial hyperthermia
  208. Spatial temperature control with a 27 MHz current source interstitial hyperthermia system
  209. The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: Importance of longitudinal control
  210. Numerical analysis of capacitively coupled electrodes for interstitial hyperthermia
  211. Basics of Thermal Models
  212. Principles of Treatment Planning
  213. The theoretical and experimental evaluation of the heat balance in perfused tissue
  214. Dose uniformity in scanned focused ultrasound hyperthermia
  215. Thermal Model Verification in Interstitial Hyperthermia
  216. Thermal Modeling of Vascular Patterns and Their Impact on Interstitial Heating Technology and Temperature Monitoring
  217. Temperature and SAR measurements in deep-body hyperthermia with thermocouple thermometry
  218. Interstitial heating: experiments in artificially perfused bovine tongues
  219. Experimental verification of bioheat transfer theories: measurement of temperature profiles around large artificial vessels in perfused tissue
  220. Generation of a rapid step in the temperature of a papillary muscle
  221. Evaluation of actual 3D temperature distributions using a discrete vasculature (DiVa) thermal model